Ohcanbohtosat - Ofer Perzon

Understanding gut microbial diversity using systems based on the Constrained-Disorder Principle provides a novel approach to targeting gut microbiome therapies Dahkki Ofer Perzon, Yaron Ilan

Viečča ollesdeavstta

The effect of a treatment switch to integrase Strand transfer inhibitor–based regimens on weight gain and other metabolic syndrome-related conditions Dahkki Omer Maman, Wiessam Abu Ahmad, Ofer Perzon, Keren Mahlab-Guri, Daniel Elbirt, Hila Elinav

Viečča ollesdeavstta

Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes Dahkki Mohamad Suki, Johnny Amer, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Yariv Tiram, Ofer Perzon, Yousra Sharif, Joseph Sackran, Revital Alon, Nachum Emil Eliezer Lourie, Itamar Raz, Ashraf Imam, Abed Khalaileh, Rifaat Safadi

Viečča ollesdeavstta

SGLT2 Inhibitors in MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) Associated with Sustained Hepatic Benefits, Besides the Cardiometabolic Dahkki Mohamad Suki, Ashraf Imam, Johnny Amer, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Yariv Tiram, Ofer Perzon, Yousra Sharif, Joseph Sackran, Revital Alon, Nachum Lourie, Anat Hershko Klement, Safa Shibli, Tamer Safadi, Itamar Raz, Abed Khalaileh, Rifaat Safadi

Viečča ollesdeavstta